
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Envista Holdings Corp (NVST)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: NVST (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $19.04
1 Year Target Price $19.04
3 | Strong Buy |
0 | Buy |
10 | Hold |
0 | Sell |
1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -20.37% | Avg. Invested days 29 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.33B USD | Price to earnings Ratio - | 1Y Target Price 19.04 |
Price to earnings Ratio - | 1Y Target Price 19.04 | ||
Volume (30-day avg) 14 | Beta 1 | 52 Weeks Range 14.22 - 23.00 | Updated Date 06/30/2025 |
52 Weeks Range 14.22 - 23.00 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -6.54 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -44.9% | Operating Margin (TTM) 7.99% |
Management Effectiveness
Return on Assets (TTM) 1.57% | Return on Equity (TTM) -31.33% |
Valuation
Trailing PE - | Forward PE 19.68 | Enterprise Value 3817009545 | Price to Sales(TTM) 1.33 |
Enterprise Value 3817009545 | Price to Sales(TTM) 1.33 | ||
Enterprise Value to Revenue 1.52 | Enterprise Value to EBITDA 24.09 | Shares Outstanding 169487008 | Shares Floating 168902283 |
Shares Outstanding 169487008 | Shares Floating 168902283 | ||
Percent Insiders 0.54 | Percent Institutions 117.39 |
Analyst Ratings
Rating 4 | Target Price 19.04 | Buy - | Strong Buy 3 |
Buy - | Strong Buy 3 | ||
Hold 10 | Sell - | Strong Sell 1 | |
Strong Sell 1 |
Upturn AI SWOT
Envista Holdings Corp
Company Overview
History and Background
Envista Holdings Corp. was formed in 2019 when Danaher Corporation spun off its dental business. Danaher had been building its dental portfolio for decades through numerous acquisitions, establishing a leading position in the dental industry.
Core Business Areas
- Specialty Products & Technologies: This segment encompasses a diverse range of products used by dental professionals, including implants, orthodontics (braces and aligners), and related equipment and supplies.
- Equipment & Consumables: This segment includes dental equipment such as imaging systems, handpieces, and consumables like restoratives, cements, and infection control products.
Leadership and Structure
Amir Aghdaei serves as the Chief Executive Officer. The company operates with a decentralized structure, empowering individual business units while leveraging shared resources and expertise across the organization. Envista Holdings Corp. is listed on the New York Stock Exchange under the symbol NVST.
Top Products and Market Share
Key Offerings
- Nobel Biocare (Implants): Nobel Biocare is a leading brand in dental implants, offering a comprehensive range of implant systems and related products. It has a significant market share in the global dental implant market, estimated to be around 18%. Competitors include Straumann, Danaher's (DHR) KaVo Kerr, and Dentsply Sirona (XRAY).
- Ormco (Orthodontics): Ormco is a major player in orthodontics, providing braces, aligners (Spark Clear Aligners) and related products. The Invisalign brand of Align Technology (ALGN) is a major competitor, along with others such as 3M Unitek.
- KaVo Kerr (Equipment & Consumables): KaVo Kerr manufactures a variety of dental equipment and consumables, with products ranging from X-ray machines to handpieces and dental filling materials. Other competitors include Planmeca and Dentsply Sirona (XRAY).
Market Dynamics
Industry Overview
The dental industry is characterized by steady growth, driven by factors such as an aging population, increasing awareness of oral health, and rising disposable incomes. Digital dentistry, including CAD/CAM systems and 3D printing, is transforming the industry. However, it is also sensitive to consumer spending and economic downturns.
Positioning
Envista Holdings Corp. holds a leading position in the dental industry, with a strong portfolio of established brands and a diversified product offering. Its competitive advantages include its global reach, strong distribution network, and focus on innovation.
Total Addressable Market (TAM)
The global dental market is estimated to be around $40-50 billion. Envista Holdings Corp. is positioned well to capture a significant share of this market due to its diverse portfolio and global presence.
Upturn SWOT Analysis
Strengths
- Strong Brand Portfolio
- Global Presence
- Extensive Distribution Network
- Focus on Innovation
- Recurring Revenue Streams (consumables)
- Experienced Management Team
Weaknesses
- Exposure to Economic Cycles
- Integration Risks from Acquisitions
- Dependence on Key Brands
- Higher levels of debt from spin-off
- Spark Clear Aligners lagging against Invisalign in the Orthodontics market
Opportunities
- Growth in Emerging Markets
- Expansion in Digital Dentistry
- Increasing Demand for Cosmetic Dentistry
- Strategic Acquisitions
- Partnerships with dental professionals
Threats
- Intense Competition
- Technological Disruption
- Changing Regulatory Landscape
- Economic Downturn
- Pricing Pressures
Competitors and Market Share
Key Competitors
- XRAY
- ALGN
- DHR
Competitive Landscape
Envista possesses strengths in equipment, consumables, and implants while competitors have better positions in orthodontics and digital dentistry. Envista's decentralized structure offers flexibility but may lack synergy.
Major Acquisitions
Carestream Dental Intraoral Scanners
- Year: 2024
- Acquisition Price (USD millions): 600
- Strategic Rationale: This acquisition strengthens Envista's position in the digital dentistry market, providing a comprehensive portfolio of intraoral scanning solutions. It allows Envista to broaden its offering and integrate this with its existing product line, thus creating more customer value.
OsteoReady
- Year: 2024
- Acquisition Price (USD millions): 75
- Strategic Rationale: This acquisition increases Envista's market share in bone regeneration materials, enabling the company to provide comprehensive solutions for its dental implant customers.
Growth Trajectory and Initiatives
Historical Growth: Envista's growth has been driven by organic growth, new products, and acquisitions. A sample of historical growth values is: Organic Growth [%]: [5.6, 5.8, 3.0]
Future Projections: Analysts estimate continued growth, driven by increasing demand for dental products and services, especially in emerging markets. Requires analysis of analyst estimates and guidance.
Recent Initiatives: Recent initiatives include investments in digital dentistry solutions, product development, and strategic acquisitions to expand market share.
Summary
Envista Holdings Corp. is a key player in the dental industry. It has a strong portfolio and global reach. Challenges remain regarding integration efforts of acquired assets. Competition, especially in orthodontics, require monitoring as well as potential new regulatory and compliance standards which could affect pricing.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (Annual Reports, Investor Presentations), Analyst Reports (e.g., from major investment banks), Market Research Reports (e.g., from industry-specific firms), Press Releases
Disclaimers:
This analysis is based on publicly available information and represents a general overview. Investment decisions should be based on thorough research and consultation with a financial advisor. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envista Holdings Corp
Exchange NYSE | Headquaters Brea, CA, United States | ||
IPO Launch date 2019-09-18 | CEO & Director Mr. Paul A. Keel | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 12300 | Website https://envistaco.com |
Full time employees 12300 | Website https://envistaco.com |
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.